Literature DB >> 16342405

Enhanced proliferation, attachment and osteopontin expression by porcine periodontal cells exposed to Emdogain.

J C Rincon1, Y Xiao, W G Young, P M Bartold.   

Abstract

Emdogain (EMD) is an enamel matrix derivative extracted from developing porcine teeth with demonstrated periodontal regenerative potential. EMD has been shown to influence a number of properties of periodontal ligament cells including proliferation, cell attachment and matrix synthesis. To date, the effect of EMD on the epithelial cell rests of Malassez (ERM) is unknown. In this study, periodontal ligament fibroblasts, ERM, alveolar bone cells and gingival fibroblasts were obtained from porcine periodontal ligament, alveolar bone and gingiva. This study investigated, in vitro, the effect of EMD at three concentrations on proliferation, cell attachment and expression of mRNA for two mineralised tissue-related proteins (osteopontin and bone sialoprotein). As for other periodontal cells, the ERM proliferative response was enhanced by EMD. Attachment assays revealed a highly significant increase for ERM and gingival fibroblasts after EMD treatment at all concentrations. This study has also shown that EMD stimulated expression of osteopontin mRNA by ERM and alveolar bone cells. The results from this study provide evidence that EMD enhanced cellular events related with proliferation, attachment and osteopontin mRNA expression by porcine periodontal cells, in a manner consistent with its role in periodontal regenerative therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16342405     DOI: 10.1016/j.archoralbio.2005.04.006

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  3 in total

1.  Effect of enamel matrix derivative on wound healing following gingival recession coverage using the modified coronally advanced tunnel and subepithelial connective tissue graft: a randomised, controlled, clinical study.

Authors:  Alexandra Stähli; Jean-Claude Imber; Elena Raptis; Giovanni E Salvi; Sigrun Eick; Anton Sculean
Journal:  Clin Oral Investig       Date:  2019-07-09       Impact factor: 3.573

2.  Human gingival fibroblast response to enamel matrix derivative, porcine recombinant 21.3-kDa amelogenin and 5.3-kDa tyrosine-rich amelogenin peptide.

Authors:  Marzena Wyganowska-Swiatkowska; Paulina Urbaniak; Daniel Lipinski; Marlena Szalata; Malgorzata Kotwicka
Journal:  Hum Cell       Date:  2017-05-03       Impact factor: 4.174

3.  In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives.

Authors:  Christoph Reichert; Bilal Al-Nawas; Ralf Smeets; Adrian Kasaj; Werner Götz; Marcus O Klein
Journal:  Head Face Med       Date:  2009-11-12       Impact factor: 2.151

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.